Sonic Healthcare holds AGM after posting strong FY25 growth and reaffirming FY26 outlook

Sonic Healthcare booked 8% FY25 sales growth, reaffirmed its FY26 outlook, and completed a major acquisition.

Key points
  • Sonic Healthcare reported an 8% rise in both statutory revenue to A$9,645 million and EBITDA to A$1,725 million for FY2025, alongside a 6% EPS increase to 106.7 cents.
  • The company confirmed FY26 EBITDA guidance of A$1.87–1.95 billion, supported by acquisitions like LADR Laboratory Group in Germany and strong revenue growth.
  • Looking forward, Sonic plans to maintain organic growth, focus on cost control and EPS enhancement, and continue its progressive dividend strategy amid recent market underperformance.

The Sonic Healthcare Ltd (ASX: SHL) share price is in focus after the company reaffirmed its FY26 earnings guidance and posted 8% revenue and EBITDA growth for FY2025.

A group of people in a corporate setting do a collective high five.

Image source: Getty Images

What did Sonic Healthcare report in FY25?

  • Statutory revenue for FY2025 rose 8% year-over-year to A$9,645 million
  • EBITDA increased by 8% to A$1,725 million
  • Net profit climbed 7% to A$514 million
  • Earnings per share improved by 6% to 106.7 cents
  • Total FY2025 dividends of $1.07 per share, up 1% on the prior year
  • Cash generated from operations jumped 21% to A$1,297 million

What else do investors need to know?

Sonic Healthcare confirmed its FY26 EBITDA guidance range of A$1.87–1.95 billion (on constant currency), targeting up to 13% growth on FY25. Year-to-date statutory revenue as of October 2025 grew 17%, with organic revenue up 5%, supported by recent acquisitions and contract wins.

The company completed the acquisition of LADR Laboratory Group in Germany, marking a significant milestone. This deal, partly funded by issuing new Sonic shares, is expected to deliver immediate earnings per share accretion and strong returns after synergies.

What's next for Sonic Healthcare?

Looking ahead, Sonic Healthcare expects first-half weighting for FY2026 earnings to follow historical patterns, after an atypical FY2025. The company plans to sustain organic growth through innovation in pathology and diagnostics as well as pursue further targeted acquisitions.

Management is focused on controlling costs, boosting earnings per share, and extracting value from recent acquisitions, while maintaining a progressive dividend policy supported by ongoing strong cash flows.

Sonic Healthcare share price snapshot

Over the past 12 months, Sonic shares have fallen 23%, underperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 1% over the same period.

View Original Announcement

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

More on ASX Share Market News

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Frustrated man looking exhausted while sitting at his desk with his laptop and carrying his glasses in his hand.
ASX Share Market News

5 things to watch on the ASX 200 on Tuesday

It looks set to be a tough session for Aussie investors.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

rubbish bins
Opinions

I've always loved Wesfarmers shares. But after a trip to Kmart, I'm not so sure

A weekend trip took some gloss off this stock.

Read more »

Sad man sitting at desk and grabbing his head as he looks at a laptop.
ASX Share Market News

These are the 10 most shorted ASX shares

Short sellers are targeting these shares this week. Let's find out why.

Read more »

Woman looking at her computer and pondering something.
ASX Share Market News

5 things to watch on the ASX 200 on Monday

Will the market start the week strongly? Here's what you need to know.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A geeky-looking young man with glasses bites down onto a computer keyboard in frustration or despair.
ASX Share Market News

Tech shares led the ASX 200 amid NVIDIA scandal and Microsoft outage last week

Xero's 1H FY27 results and a strong lead from Wall Street pushed the tech sector higher.

Read more »